Archive for April 26th, 2012

BioPharmCatalyst ASCO 2012 Calendar has been added!

Apr 26, 2012 No Comments by

I am pleased to announce that the ASCO 2012 Calendar has been added to BioPharmCatalyst. You can find it next to the FDA Calendar tab. Abstract numbers, presentation types and times, drugs and indications are all available in the calendar.  Links to abstracts will be added as soon as they are uploaded onto the ASCO website on […]

Articles Read more

FURX issued CRL. PGNX PDUFA delay. INCY SPPI ANTH pipeline updates. TSPT offering + TRGT news

Apr 26, 2012 No Comments by

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) said today that its partner Takeda Pharmaceutical Company Limited received a complete response letter (CRL) from the FDA for alogliptin, and the fixed-dose combination therapy alogliptin and pioglitazone. The FDA has requested additional data. Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) and Progenics Pharmaceuticals (NASDAQ: PGNX)  announced that the FDA has extended the PDUFA date of their […]

Daily News Read more